Approved Selank/Semax 10

Selank and Semax are two synthetic peptides originally developed in Russia for their neurological and cognitive-modulating properties. Both are analogs of naturally occurring regulatory peptides:

• Selank is a heptapeptide derived from tuftsin, with notable anxiolytic, neuroprotective, and immune-modulating activity.
• Semax is a synthetic analog of ACTH(4-10), designed to exert nootropic, neuroprotective, and neurotrophic effects without the hormonal side effects of ACTH.

Individually, each peptide has been studied for decades. When combined, they represent a powerful investigational pairing that may enhance cognition, stress resilience, memory, and neuroprotection through complementary pathways.

Research Applications and Benefits

The Selank + Semax blend is of interest in several domains of neurobiology:

Cognitive Enhancement
Semax has been studied for improved learning, memory formation, and mental performance, while Selank adds a stabilizing, anti-anxiety effect that may optimize cognitive performance under stress.

Stress and Anxiety Regulation
Selank has demonstrated anxiolytic properties without sedation, while Semax contributes to dopaminergic and serotonergic balance, supporting resilience under psychological or physical stress.

Neuroprotection
Both peptides have been investigated for their ability to protect neurons against oxidative stress and ischemic injury, making the blend of interest in models of neurodegenerative disease and brain trauma.

Immune Modulation
Selank influences immune signaling, while Semax may support anti-inflammatory pathways, suggesting potential synergy in balancing immune-neuro interactions.

Mood and Motivation
Preclinical findings suggest Semax supports dopamine regulation, while Selank modulates GABA and serotonin systems — together contributing to improved mood stability and motivation.

As with all peptides sold for research purposes only, the Selank + Semax blend is not approved for human use, supplementation, or therapeutic application. Key notes include:

• Stability – Typically supplied in lyophilized form for maximum stability. Proper storage in a cool, dry environment is essential.
• Regulatory Status – While both peptides have been studied extensively and used clinically in Russia, they remain unapproved by the FDA and investigational worldwide.
• Research Integrity – The blend should only be studied in controlled laboratory environments under strict compliance with local and federal regulations.

The Selank + Semax blend represents a unique synergy of two neuropeptides that complement one another:

• Selank provides anxiolytic and immune-modulating properties.
• Semax contributes cognitive enhancement, neuroprotection, and dopaminergic support.

Together, they offer researchers a comprehensive toolset for investigating the intersection of cognition, stress, mood, and brain resilience.